PLA2G4B antibody (AA 514-781)
Quick Overview for PLA2G4B antibody (AA 514-781) (ABIN7149404)
Target
See all PLA2G4B AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 514-781
-
Cross-Reactivity
- Human
-
Purification
- >95%, Protein G purified
-
Immunogen
- Recombinant Human Cytosolic phospholipase A2 beta protein (514-781AA)
-
Isotype
- IgG
-
-
-
-
Application Notes
- Recommended dilution: WB:1:1000-1:5000, IHC:1:200-1:500, IF:1:50-1:200,
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 -
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C,-80 °C
-
Storage Comment
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- PLA2G4B (Phospholipase A2, Group IVB (Cytosolic) (PLA2G4B))
-
Alternative Name
- PLA2G4B
-
Background
-
Background: Calcium-dependent phospholipase A2 that selectively hydrolyzes glycerophospholipids in the sn-2 position with a preference for arachidonoyl phospholipids. Has a much weaker activity than PLA2G4A. Isoform 3 has calcium-dependent activity against palmitoyl-arachidonyl-phosphatidylethanolamine and low level lysophospholipase activity but no activity against phosphatidylcholine. Isoform 5 does have activity against phosphatidylcholine.
Aliases: PLA2G4B antibody, Cytosolic phospholipase A2 beta antibody, cPLA2-beta antibody, EC 3.1.1.4 antibody, Phospholipase A2 group IVB antibody
-
UniProt
- P0C869
-
Pathways
- ER-Nucleus Signaling, VEGF Signaling
Target
-